Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...

Kenvue Inc. (KVUE), a global consumer health company, is dedicated to delivering trusted personal care, health, and wellness ...

Kenvue Inc. closed 12.96% below its 52-week high of $24.46, which the company reached on November 26th.

Kenvue (NYSE:KVUE – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $21.00. The ...

This was the stock's second consecutive day of gains.

L’Oréal veteran Penelope Giraud will lead the direction of the company’s beauty brands Neutrogena, Aveeno and Dr. Ci Labo in ...

These Dividend Stocks Fell Between 1% and 20% in 2024. Here's Why They Are Too Cheap to Ignore and Worth Buying in 2025.

Have you ever felt overlooked or unseen? Kenvue's Joy Ogunneye knows that feeling all too well. Back in college, while ...

Kenvue (KVUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.